Published in Aging and Elder Health Week, February 13th, 2005
The trial in Spain, called Remit, included 39 patients who had previously received Remune in an open label study, who were then randomized to receive blinded Remune or Incomplete Freud's Adjuvant (IFA) during Remit, and a comparative control group of 19 subjects.
This trial was designed as an exploratory phase 2 trial with multiple endpoints to give...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging and Elder Health Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.